| Title | Synthetic Biology Market to Hit USD 31.52 Billion by 2029 |
|---|
| URL | https://www.prnewswire.com/news-releases/synthetic-biology-market-to-hit-usd-31-52-billion-by-2029-with-20-6-cagr--marketsandmarkets-302300950.html |
|---|
| Category | Fitness Health --> Health Articles |
|---|
| Meta Keywords | synthetic biology market |
|---|
| Meta Description | The tool segment is segmented into oligonucleotides & synthetic DNA, enzymes, cloning technology kits, chassis organisms, xeno nucleic acids and synthetic cells. |
|---|
| Owner | Healthcare101 |
|---|
| Description |
|---|
| The global synthetic biology market is anticipated to reach USD 31.52 billion in 2029 from USD 12.33 billion in 2024, with a significant CAGR of 20.6%. The major factors contributing towards the growth of the synthetic biology market include the diversified applications of synthetic biology and the bio-based products rising demand. Furthermore, the advancements in synthetic biology and rising funding in R&D and collaborations is likely to drive market adoption in the coming years. |
